Risk factors for non-adherence to antidepressant treatment in patients with mood disorders

European Journal of Clinical Pharmacology

Volumn 70, Issue 1, 2014, Pages 89-98

  De Las Cuevas, Carlos ^a,b   Peñate, Wenceslao ^a   Sanz, Emilio J ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas REDISSEC   (Spain)

Author keywords

Adherence; Mood disorders; Psychiatric outpatients; Risk factors; Self report

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; BELIEFS ABOUT MEDICINE QUESTIONNAIRE; BIPOLAR DEPRESSION; BLURRED VISION; CHECKLIST; CLINICAL ASSESSMENT; COMMUNITY MENTAL HEALTH; CONSTIPATION; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG ATTITUDE INVENTORY; DRUG SAFETY; DYSTHYMIA; FEMALE; FEVER; GLOBAL ADVERSE REACTION SEVERITY INDEX; HEADACHE; HEART PALPITATION; HUMAN; INCREASED APPETITE; INSOMNIA; LEEDS ATTITUDE TOWARDS CONCORDANCE SCALE; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MICTURITION DISORDER; MIDDLE AGED; MOOD DISORDER; MORISKY SELF REPORT SCALE; NAUSEA; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; POLYPHARMACY; POSITIVE SIDE EFFECT DISTRESS INDEX; POSITIVE SIDE EFFECT TOTAL; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; SEXUAL DYSFUNCTION; SWEATING; TREATMENT REFUSAL; TREMOR; VERY ELDERLY; VOMITING; WEIGHT GAIN; XEROSTOMIA; YAWNING;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; CULTURE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOOD DISORDERS; RISK FACTORS; SELF REPORT; SEVERITY OF ILLNESS INDEX;

EID: 84891846494     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1582-9     Document Type: Article

References (53)

1. Ables AZ, Baughman OL III (2003) Antidepressants: update on new agents and indications. Am Fam Physician 67:547-554 (Pubitemid 36182179)
2. Alonso J, Angermeyer M, Bernert S, Bruffaerts R, Brugha TS, Bryson H et al (2004) Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 420:21-27
3. Baldessarini RJ, Perry R, Pike J (2008) Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol 23(2):95-105 (Pubitemid 351359581)
4. Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 67(3):588-597 (Pubitemid 26382973)
5. Beléndez M, Hernández A, Horne R, Weinman J (2007) Evaluación de las creencias sobre el tratamiento: Validez y fiabilidad de la versión española del Beliefs about Medicines Questionnaire. Int J Health Clin Psychol 7:767-779
6. Blackwell B (1982) Antidepressant drugs: side effects and compliance. J Clin Psychiatry 43 (11 Pt 2):14-21 (Pubitemid 13208344)
7. Bockting C, ten Doesschate MC, Spijker J, Spinhoven P, Koeter MW, Schene AH (2008) Continuation and maintenance use of antidepressants in recurrent depression. Psychother Psychosom 77(1):17-26 (Pubitemid 350261944)
8. Brown C, Battista DR, Bruehlman R, Sereika SS, Thase ME, Dunbar-Jacob J (2005) Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care 43(12):1203-1207 (Pubitemid 43012177)
9. Bucci KK, Possidente CJ, Talbot KA (2003) Strategies to improve medication adherence in patients with depression. Am J Health Syst Pharm 60(24):2601-2605 (Pubitemid 44712863)
10. Bull SA, Hu XH, Hunkeler EM, Lee JY, Ming EE, Markson LE, Fireman B (2002) Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 288(11):1403-1409 (Pubitemid 35025915)
11. Castle T, Cunningham MA, Marsh GM (2012) Antidepressant medication adherence via interactive voice response telephone calls. Am J Manage Care 18(9):e346-e355
12. De las Cuevas C, Rivero A, Perestelo-Perez L, Gonzalez M, Perez J, Peñate W (2011) Psychiatric patients' attitudes towards concordance and shared decision making. Patient Educ Couns 85:e245-e250
13. De las Cuevas C, Rivero-Santana A, Perestelo-Pérez L, González-Lorenzo M, Pérez-Ramos J, Sanz EJ (2011) Adaptation and validation study of the Beliefs about Medicines Questionnaire in psychiatric outpatients in a community mental health setting. Hum Psychopharmacol Clin Exp 26:140-146
14. De las Cuevas C, Sanz EJ (2004) Polypharmacy In psychiatric practice in the Canary Islands. BMC Psychiatry 4:18 (Pubitemid 40177151)
15. De las Cuevas C, Sanz EJ (2005) Polypsychopharmacy. A frequent and debatable practice in psychiatric inpatients. J Clin Psychopharmacol 25(5):510-512 (Pubitemid 41368384)
16. Emilsson M, Berndtsson I, Lötvall J, Millqvist E, Lundgren J, Johansson A, Brink E (2011) The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Prim Care Respir J 20(2):141-147
17. Fawzi W, Abdel Mohsen MY, Hashem AH, Moussa S, Coker E, Wilson KC (2012) Beliefs about medications predict adherence to antidepressants in older adults. Int Psychogeriatr 24(1):159-169
18. Food and Drug Administration (FDA) (2012) Antidepressant use in children, adolescents, and adults. Available at: http://www.fda.gov/Drugs/DrugSafety/ InformationbyDrugClass/UCM096273
19. García Cabeza I, Hormaechea Beldarrain JA, Mr SA, Arango López C, González de Chávez M (2000) Drug attitude inventory, spanish-adapted version. Euro Neuropsychopharm 10(3):298-299
20. Gardarsdottir H, Heerdink ER, van Dijk L, Egberts AC (2007) Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord 98:109-115 (Pubitemid 46048906)
21. Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lloyd S, Reichenpfader U, Lohr KN (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med 155(11):772-785
22. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361(9358):653-661 (Pubitemid 36246547)
23. Guy W (1976) Early Clinical Drug Evaluation Unit (ECDEU) Assessment manual for psychopharmacology. National Institute of Mental Health, Bethesda
24. Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22:347-352
25. Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13:177-183 (Pubitemid 13132147)
26. Horne R, Weinman J (1999) Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illnesss. J Psychosom Res 47:555-567 (Pubitemid 30029305)
27. Horne R, Weinman J, Hankins M (1999) The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14:1-24
28. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60:261-269 (Pubitemid 36307437)
29. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59:530-537 (Pubitemid 34602935)
30. Kelly K, Posternak M, Alpert JE (2008) Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci 10(4):409-418
31. Kessing LV, Hansen MG, Andersen PK (2004) Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 185:372-377 (Pubitemid 39482072)
32. Levkovitz Y, Tedeschini E, Papakostas GI (2011) Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 72(4):509-514
33. Mahler C, Hermann K, Horne R, Jank S, Haefeli WE, Szecsenyi J (2012) Patients' beliefs about medicines in a primary care setting in Germany. J Eval Clin Pract 18(2):409-413
34. Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N, Suddath R (2000) Family-focused treatment of bipolar disorder: 1-year effects of a psycho-educational program in conjunction with pharmacotherapy. Biol Psychiatry 48:582-592
35. Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10:348-354
36. Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24:67-74 (Pubitemid 16125389)
37. Murray M, Kroenke K (2001) Polypharmacy and medication adherence: Small steps on a long road. J Gen Intern Med 16:137-139 (Pubitemid 32183574)
38. Rascati K (1995) Drug utilization review of concomitant use of specific serotonine reuptake inhibitors or clomipramine and antianxiety/sleep medications. Clin Ther 17:786-790
39. Raynor DK, Thistlethwaite JE, Hart K, Knapp P (2001) Are health professionals ready for the new philosophy of concordance in medicine taking? Int J Pharm Pract 9:81-84 (Pubitemid 32622292)
40. Reynolds CF, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, Lenze EJ, Holm M, Rogers JC, Mazumdar S, Houck PR, Begley A, Anderson S, Karp JF, Miller MD, Whyte EM, Stack J, Gildengers A, Szanto K, Bensasi S, Kaufer DI, Kamboh MI, DeKosky ST (2011) Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 68(1):51-60
41. Reynolds CF, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ (2006) Maintenance treatment of major depression in old age. N Engl J Med 354(11):1130-1138
42. Rivero-Santana A, Perestelo-Perez L, Pérez-Ramos J, Serrano-Aguilar P, Cuevas CDl (2013) Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders. A systematic review of observational studies. Patient Prefer Adherence 7:151-169
43. Roca M, Armengol S, Monzón S, Salva J, Gili M (2011) Adherence to medication in depressive patients. J Clin Psychopharmacol 31:541-543
44. Russell J, Kazantzis N (2008) Medication beliefs and adherence to antidepressants in primary care. N Z Med J 121(1286):14-20
45. Sanz J, García MP, Espinosa R, Fortún M, Vázquez C (2005) Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 3. Propiedades psicométricas en pacientes con trastornos psicológicos. Clín Salud 16:121-142
46. Shalansky SJ, Levy AR, Ignaszewski AP (2004) Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 38:1363-1368 (Pubitemid 39100185)
47. Stahl SM (2002) Antipsychotic polypharmacy: evidence based or eminence based? Acta Psychiatr Scand 106:321-322 (Pubitemid 35176873)
48. Tanaka E, Hisawa S (1999) Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. J Clin Pharm Ther 24:7-16 (Pubitemid 29171674)
49. Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, Kozel D, Hauser J, Souery D, Placentino A, Strohmaier J, Perroud N, Zobel A, Rajewska-Rager A, Dernovsek MZ, Larsen ER, Kalember P, Giovannini C, Barreto M, McGuffin P, Aitchison KJ (2009) Adverse reactions to antidepressants. Br J Psychiatry 195(3):202-210
50. Val JA, Amorós BG, Martínez VP, Fernández Ferre ML, León SM (1992) Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test. Aten Primaria 10(5):767-770
51. Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E (2011) WAVE-bd Study Group. Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study). BMC Psychiatry 11:58
52. Wheeler K, Wagaman A, McCord D (2012) Personality traits as predictors of adherence in adolescents with type I diabetes. J Child Adolesc Psychiatr Nurs 25(2):66-74
53. World Health Organization (2003) Investing in mental health. World Health Organization, Geneva